drugset / Trial / NCT00934414

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

NCT00934414

Phase 2 Completed 24 enrolled Mannkind Corporation
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Twelve smoking and twelve non-smoking subjects with Type 2 Diabetes Mellitus will be enrolled in this study to determine the effect of Technosphere® Insulin Inhalation Powder on insulin in the body during a clamp procedure.

Timeline

Start
2004-08
Primary completion
2006-08
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 30 iu Inhaled